| 0 |
PYELOCYSTITIS |
1 |
0.0833 |
| 1 |
ALCOHOL TEST POSITIVE |
1 |
0.0213 |
| 2 |
HYPERGLYCAEMIC CRISIS |
1 |
0.0192 |
| 3 |
HAEMORRHAGIC NECROTIC PANCREATITIS |
1 |
0.0133 |
| 4 |
PANCREATIC DUCT OBSTRUCTION |
2 |
0.0112 |
| 5 |
WOUND NECROSIS |
2 |
0.0042 |
| 6 |
DIABETIC RETINOPATHY |
4 |
0.0012 |
| 7 |
COVID-19 PNEUMONIA |
12 |
0.0010 |
| 8 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
4 |
0.0010 |
| 9 |
CAROTID ARTERIOSCLEROSIS |
1 |
0.0010 |
| 10 |
PANCREATITIS NECROTISING |
2 |
0.0009 |
| 11 |
DIABETIC NEUROPATHY |
4 |
0.0008 |
| 12 |
OVERWEIGHT |
4 |
0.0007 |
| 13 |
DIABETIC FOOT INFECTION |
1 |
0.0007 |
| 14 |
KETOACIDOSIS |
5 |
0.0007 |
| 15 |
GASTROSTOMY |
1 |
0.0006 |
| 16 |
BLOOD CREATININE DECREASED |
2 |
0.0006 |
| 17 |
PROTEIN TOTAL DECREASED |
2 |
0.0005 |
| 18 |
ORGAN FAILURE |
2 |
0.0005 |
| 19 |
EUGLYCAEMIC DIABETIC KETOACIDOSIS |
2 |
0.0005 |
| 20 |
DIVERTICULUM INTESTINAL HAEMORRHAGIC |
1 |
0.0004 |
| 21 |
HYPERCHOLESTEROLAEMIA |
4 |
0.0004 |
| 22 |
ENTEROCOCCAL INFECTION |
2 |
0.0004 |
| 23 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
2 |
0.0004 |
| 24 |
FLUID INTAKE REDUCED |
2 |
0.0004 |
| 25 |
POLYMYALGIA RHEUMATICA |
1 |
0.0003 |
| 26 |
HEPATIC CYTOLYSIS |
4 |
0.0003 |
| 27 |
C-REACTIVE PROTEIN ABNORMAL |
2 |
0.0003 |
| 28 |
ONYCHOCLASIS |
2 |
0.0003 |
| 29 |
NECROTISING FASCIITIS |
1 |
0.0003 |
| 30 |
BRADYCARDIA |
15 |
0.0003 |
| 31 |
BLOOD ALBUMIN DECREASED |
2 |
0.0003 |
| 32 |
HEPATIC PAIN |
1 |
0.0002 |
| 33 |
TOE AMPUTATION |
1 |
0.0002 |
| 34 |
WEIGHT LOSS POOR |
1 |
0.0002 |
| 35 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 36 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 37 |
GANGRENE |
1 |
0.0002 |
| 38 |
VULVOVAGINAL BURNING SENSATION |
1 |
0.0002 |
| 39 |
GASTROINTESTINAL HAEMORRHAGE |
12 |
0.0001 |
| 40 |
LYMPHOPENIA |
2 |
0.0001 |
| 41 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 42 |
LABORATORY TEST ABNORMAL |
4 |
0.0001 |
| 43 |
ACIDOSIS |
1 |
0.0001 |
| 44 |
GINGIVAL PAIN |
1 |
0.0001 |
| 45 |
HAIR DISORDER |
1 |
0.0001 |
| 46 |
PYELONEPHRITIS |
1 |
0.0001 |
| 47 |
CARDIAC FAILURE |
9 |
0.0001 |
| 48 |
UROSEPSIS |
1 |
0.0001 |
| 49 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 50 |
INCREASED APPETITE |
2 |
0.0001 |
| 51 |
ERUCTATION |
2 |
0.0001 |
| 52 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 53 |
HEPATOMEGALY |
1 |
0.0001 |
| 54 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 55 |
SINUS DISORDER |
2 |
0.0001 |
| 56 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 57 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 58 |
FUNGAL INFECTION |
3 |
0.0001 |
| 59 |
TRANSAMINASES INCREASED |
2 |
0.0001 |
| 60 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 61 |
MADAROSIS |
1 |
0.0001 |
| 62 |
HYPERGLYCAEMIA |
3 |
0.0001 |
| 63 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 64 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 65 |
HAIR COLOUR CHANGES |
1 |
0.0001 |
| 66 |
DYSPNOEA EXERTIONAL |
3 |
0.0001 |
| 67 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 68 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 69 |
COVID-19 |
13 |
0.0001 |
| 70 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 71 |
LUNG INFECTION |
1 |
0.0001 |
| 72 |
BRAIN FOG |
1 |
0.0001 |
| 73 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 74 |
CHOLELITHIASIS |
2 |
0.0001 |
| 75 |
VIRAL INFECTION |
2 |
0.0001 |
| 76 |
URINARY RETENTION |
2 |
0.0001 |
| 77 |
CANDIDA INFECTION |
1 |
0.0001 |
| 78 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 79 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 80 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 81 |
GOUT |
1 |
0.0001 |
| 82 |
TOOTHACHE |
1 |
0.0001 |
| 83 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 84 |
BLOOD GLUCOSE INCREASED |
10 |
0.0001 |
| 85 |
SKIN FISSURES |
1 |
0.0001 |
| 86 |
FEEDING DISORDER |
1 |
0.0000 |
| 87 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 88 |
LIVER DISORDER |
2 |
0.0000 |
| 89 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 90 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 91 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 92 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 93 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 94 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 95 |
TARDIVE DYSKINESIA |
1 |
0.0000 |
| 96 |
NASAL CONGESTION |
2 |
0.0000 |
| 97 |
NO ADVERSE EVENT |
6 |
0.0000 |
| 98 |
VOMITING |
15 |
0.0000 |
| 99 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 100 |
PRODUCT DOSE OMISSION |
2 |
0.0000 |
| 101 |
PRODUCT DOSE OMISSION ISSUE |
9 |
0.0000 |
| 102 |
DYSPEPSIA |
3 |
0.0000 |
| 103 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 104 |
HYPERTENSION |
6 |
0.0000 |
| 105 |
DYSPNOEA |
16 |
0.0000 |
| 106 |
DYSURIA |
1 |
0.0000 |
| 107 |
EPISTAXIS |
2 |
0.0000 |
| 108 |
DYSARTHRIA |
1 |
0.0000 |
| 109 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 110 |
CARDIAC ARREST |
2 |
0.0000 |
| 111 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 112 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 113 |
MENTAL DISORDER |
1 |
0.0000 |
| 114 |
THROAT IRRITATION |
1 |
0.0000 |
| 115 |
RENAL DISORDER |
1 |
0.0000 |
| 116 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 117 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 118 |
COMA |
1 |
0.0000 |
| 119 |
ALOPECIA |
4 |
0.0000 |
| 120 |
ILLNESS |
2 |
0.0000 |
| 121 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 122 |
PANCREATITIS |
1 |
0.0000 |
| 123 |
OEDEMA |
1 |
0.0000 |
| 124 |
SEPSIS |
2 |
0.0000 |
| 125 |
JOINT SWELLING |
2 |
0.0000 |
| 126 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 127 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 128 |
VISION BLURRED |
2 |
0.0000 |
| 129 |
SLEEP DISORDER |
1 |
0.0000 |
| 130 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 131 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 132 |
PARAESTHESIA |
2 |
0.0000 |
| 133 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 134 |
MYALGIA |
2 |
0.0000 |
| 135 |
RASH |
5 |
0.0000 |
| 136 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 137 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 138 |
HEART RATE INCREASED |
1 |
0.0000 |
| 139 |
SYNCOPE |
1 |
0.0000 |
| 140 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 141 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 142 |
WEIGHT INCREASED |
2 |
0.0000 |
| 143 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 144 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 145 |
PSORIASIS |
1 |
0.0000 |
| 146 |
WEIGHT DECREASED |
2 |
0.0000 |
| 147 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 148 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 149 |
DRUG INTERACTION |
1 |
0.0000 |
| 150 |
URTICARIA |
1 |
0.0000 |
| 151 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 152 |
MUSCLE SPASMS |
1 |
0.0000 |
| 153 |
CHEST PAIN |
1 |
0.0000 |
| 154 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 155 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 156 |
SOMNOLENCE |
1 |
0.0000 |
| 157 |
MALAISE |
2 |
0.0000 |
| 158 |
FEELING ABNORMAL |
1 |
0.0000 |
| 159 |
INSOMNIA |
1 |
0.0000 |
| 160 |
COUGH |
1 |
0.0000 |
| 161 |
DRUG INEFFECTIVE |
4 |
0.0000 |
| 162 |
FATIGUE |
2 |
0.0000 |
| 163 |
ARTHRALGIA |
1 |
0.0000 |
| 164 |
DIZZINESS |
1 |
0.0000 |
| 165 |
PAIN |
1 |
0.0000 |
| 166 |
HEADACHE |
1 |
0.0000 |
| 167 |
DIARRHOEA |
1 |
0.0000 |
| 168 |
DEATH |
1 |
0.0000 |
| 169 |
OFF LABEL USE |
1 |
0.0000 |